Critical appraisal:Beydoun N, Graham PH, Browne L 2012 2

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Highly selected or not described
Comparison group
Highly selected or not described
Comparability of groups on demographic characteristics and clinical features
Not comparable and not adjusted for differences
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Yes
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
High risk of bias Additional comments:


Jutta's tick icon.png This appraisal has been completed.


Article
Beydoun N, Graham PH, Browne L. Metastatic Cutaneous Squamous Cell Carcinoma to the Axilla: A Review of Patient Outcomes and Implications for Future Practice. World J Oncol 2012 Oct;3(5):217-226 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29147309.
Assigned to
User:Annika.stollery
Topic area
Guidelines:Keratinocyte carcinoma
Clinical question
Form
Form:Quality appraisal cohort
Outcomes
Toxicity; Recurrence; Local control; Overall survival

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment